Evidence map›Paper›PMID 34065945›Full record

ArticleInternational journal of environmental research and public health2021

Oncotype DX Test Receipt among Latina/Hispanic Women with Early Invasive Breast Cancer in New Jersey: A Registry-Based Study.

Nicholas Acuna, Jesse J Plascak, Jennifer Tsui, Antoinette M Stroup, Adana A M Llanos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/Ethnicity.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicholas AcunaDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90032, USA.
Jesse J PlascakDepartment of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Jennifer TsuiDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90032, USA.
Antoinette M StroupDepartment of Biostatistics & Epidemiology, Rutgers School of Public Health, Piscataway, NJ 08854, USA.
Adana A M LlanosDepartment of Biostatistics & Epidemiology, Rutgers School of Public Health, Piscataway, NJ 08854, USA.ORCID 0000-0001-9954-9121

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
NEW JERSEY CANCER PREVENTION & CONTROL PROGRAMU58DP003931 · DP · NEW JERSEY STATE DEPT/HEALTH/SENIOR SRVS · PI RODRIQUEZ, GLORIA · 2012 to 2014
$11.9M
NCCDPHP CDC HHS U58 DP003931NCI NIH HHS P30CA072720University of Texas Health Science Center at San Antonio 2R25CA134301-06
6 · The paper itself

Abstract

Oncotype DX

Indexed as

Breast NeoplasmsAgedFemaleGene Expression ProfilingGenetic TestingHispanic or LatinoHumansNeoplasm Recurrence, LocalNew JerseyRegistries21-gene assaybreast cancerLatina/Hispanic womenOncotype DX®recurrence risk scores

Identifiers

PMID34065945
PMCPMC8151910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.